The UVA Health system is losing another top executive, as the University Medical Center CEO, Wendy Horton, is leaving in September.

A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...

Two officials at the center of an employee revolt at UVA Health and the University of Virginia will be gone this academic ...

Kibbe’s departure marks the end of an ongoing battle between U.Va. Health employees and their senior leadership.

Any hope that the resignation of the University of Virginia Health System's CEO last month would clear the cloud of scandal hanging over the embattled health care provider was dashed Thursday. On ...

Sentara could have made a profound impact on local health had it invested its $1.5 billion in Hampton Roads, Bruce Holbrook ...

In the weeks since the CEO of the University of Virginia Health System resigned, current and former UVa officials have come forward to defend Dr. Craig Kent and lambast the school for forcing out ...

Dr. Melina Kibbe is currently chief health affairs officer at UVA Health and dean of the University of Virginia School of Medicine.

Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...

Wendy Horton, PharmD, CEO of UVA Health University Medical Center in Charlottesville, Va., will leave the organization in September for a new role. Dr. Horton has been named senior vice president and ...

Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...

Melina R. Kibbe has been named the sole finalist for the presidency of UTHealth Houston, succeeding interim President LaTanya ...